Disease, Disability and Injury Prevention and Control Special Emphasis Panel: African American Community-Based Human Immunodeficiency Virus (HIV) Prevention Special Emphasis Panel (SEP): Cooperative Agreements for African American Community-Based Human Immunodeficiency Virus (HIV) Prevention

[Federal Register Volume 64, Number 139 (Wednesday, July 21, 1999)]
[Notices]
[Page 39145]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-18547]



[[Page 39145]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability and Injury Prevention and Control Special 
Emphasis Panel: African American Community-Based Human Immunodeficiency 
Virus (HIV) Prevention Special Emphasis Panel (SEP): Cooperative 
Agreements for African American Community-Based Human Immunodeficiency 
Virus (HIV) Prevention

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following meeting.

    Name: Disease, Disability and Injury Prevention and Control 
Special Emphasis Panel: African American Community-Based Human 
Immunodeficiency Virus (HIV) Prevention Special Emphasis Panel 
(SEP): Cooperative Agreements for African American Community-Based 
Human Immunodeficiency Virus (HIV) Prevention, Program Announcement 
#99092, meeting.
    Times and Dates:

8:30 a.m.-9:00 a.m., July 26, 1999 (Open)
9:00 a.m.-4:30 p.m., July 26, 1999 (Closed)
8:30 a.m.-4:30 p.m., July 27, 1999 (Closed)
8:30 a.m.-4:30 p.m., July 28, 1999 (Closed)
8:30 a.m.-4:30 p.m., July 29, 1999 (Closed)
8:30 a.m.-4:30 p.m., July 30, 1999 (Closed)

    Place: Professional and Scientific Associates (PSA), 2635 
Century Parkway, Suite 990, Atlanta, Georgia, 30345.
    Status: Portions of the meeting will be closed to the public in 
accordance with provisions set forth in section 552b(c)(4) and (6), 
Title 5 U.S.C., and the Determination of the Associate Director for 
Management and Operations, CDC, pursuant to Public Law 92-463.
    Matters To Be Discussed: The meeting will include the review, 
discussion, and evaluation of applications received in response to 
Program Announcement #99092.
    Contact Person for More Information: Megan Foley, Prevention 
Support Office, National Center for HIV, STD, and TB Prevention, 
CDC, Corporate Square Office Park, 11 Corporate Square Boulevard, M/
S E07, Atlanta, Georgia 30329, telephone 404/639-8025, e-mail 
MZF3@cdc.gov or Beth Wolfe at the same address and telephone, e-mail 
EOW1@cdc.gov.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register Notices pertaining 
to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention 
and the Agency for Toxic Substances and Disease Registry.

    Dated: July 15, 1999.
Carolyn J. Russell,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention (CDC).
[FR Doc. 99-18547 Filed 7-16-99; 1:49 pm]
BILLING CODE 4163-18-P